Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Ovarian Cancer Diagnostics Market to reach USD 2.47 billion by the end of 2030

Global Ovarian Cancer Diagnostics Market Size study & Forecast, by Diagnosis Type (Imaging, Blood Test, Biopsy, Others), by Cancer Type (Epithelial Tumor, Stromal Cell Tumor, Germ Cell Tumor, Others), by End Use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others), and Regional Analysis, 2023-2030

Product Code: HLSMD-22997181
Publish Date: 15-11-2023
Page: 200

Global Ovarian Cancer Diagnostics Market is valued at approximately USD 1.53 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2023-2030. Ovarian cancer is a type of cancer that starts in the ovaries, which are the female organs responsible for producing eggs. This cancer is most commonly found in women aged 50 to 79 and is becoming more prevalent as the world’s elderly population grows. Early detection and treatment are key in managing ovarian cancer, and initiatives by governments and organizations are driving market growth. However, a lack of skilled professionals hinder the market growth.

The increasing number of cases of ovarian cancer across the globe is driving the market. According to a report by the National Cancer Institute in the US, the rate of new cases of ovarian cancer is 10.3 per 100,000 women per year, with a death rate of 6.3 per 100,000 women per year. This shows how lethal this disease be. Governments and organizations are investing in research and development for ovarian cancer diagnosis and treatment which is boosting the market growth. Such as the Ovarian Cancer Research Alliance (OCRA), a non-profit organization. Additionally, healthcare expenditure for cancer treatment is increasing, allowing patients to access advanced diagnostics and treatment for faster recovery. Market players are also launching innovative products, such as Inex Innovate’s OvaCis Rapid test for ovarian cancer detection, which boosts the overall market growth. However, due to costlier cancer treatment it poses challenges to market growth. According to the report of the National Cancer Institute, in 2018, costs for cancer care were estimated at USD 201.19 billion, projected to increase to USD 208.9 billion in 2020 due to population growth and aging. This impact market growth until 2030.

The key regions considered for the Global Ovarian Cancer Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The region’s growth can also be attributed to favorable government initiatives, increased healthcare expenditure, and the presence of key manufacturers. The American Cancer Society estimates that about 19,710 women in the US would be receiving a new diagnosis of ovarian cancer in 2023, with approximately 13,270 women dying from the disease. Ovarian cancer ranks fifth in cancer deaths among women, in U.S. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as overall economic development, improved healthcare infrastructure, increased disposable income, and greater consumer awareness.

Major market player included in this report are:
Abcam plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
AstraZeneca plc
Siemens Healthcare GmbH
Quest Diagnostics Incorporated.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Abbott. Laboratories Inc.

Recent Developments in the Market:
Ø In November 2022, Myriad Genetics Inc. announced, it had acquired Gateway Genomics, LLC to strengthen its portfolio of Women’s Health products. This move aims to enhance their Women’s Health products portfolio, providing personalized genetic tests that can be accessed during and after a woman’s reproductive stage. With SneakPeek, Myriad can now offer genetic insights earlier in pregnancy, providing women with valuable data throughout their lifetime. The company’s Prequel non-invasive prenatal screen, Foresight carrier screen, and MyRisk Hereditary Cancer Test with Risk Scores for all ancestries are expected to increase revenue.
Ø In November 2022, Roche’s VENTANA FOLR1 (FOLR1-2.1) RxDx Assay became the first IHC-based companion diagnostic to receive FDA approval. It can identify ovarian cancer patients eligible for ELAHERE, providing a new option for treatment.
Ø In November 2021, the USFDA approved an imaging drug called Cytalux (pafolcianine) that illuminates ovarian cancer tissue when exposed to fluorescent light, making it easier and more precise for surgeons to remove the cancer.

Global Ovarian Cancer Diagnostics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Diagnosis Type, Cancer Type, End Use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnosis Type:
Blood Test

By Cancer Type:
Epithelial Tumor
Germ Cell Tumor
Stromal Cell Tumor

By End Use:
Hospital Laboratories
Cancer Diagnostic Centers
Research Institutes

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Ovarian Cancer Diagnostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Ovarian Cancer Diagnostics Market, by Diagnosis Type, 2020-2030 (USD Billion)
1.2.3. Ovarian Cancer Diagnostics Market, by Cancer Type, 2020-2030 (USD Billion)
1.2.4. Ovarian Cancer Diagnostics Market, by End Use, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Ovarian Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Ovarian Cancer Diagnostics Market Dynamics
3.1. Ovarian Cancer Diagnostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising prevalence of ovarian cancer Increasing emphasis on early diagnosis & treatment Increase in the number of initiatives by governments
3.1.2. Market Challenges Lack of trained professionals High Cost of Diagnosis
3.1.3. Market Opportunities Increasing Healthcare Expenditure for Cancer Diagnosis and Treatment Innovative launches by the market players
Chapter 4. Global Ovarian Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Ovarian Cancer Diagnostics Market, by Diagnosis Type
5.1. Market Snapshot
5.2. Global Ovarian Cancer Diagnostics Market by Diagnosis Type, Performance – Potential Analysis
5.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by Diagnosis Type 2020-2030 (USD Billion)
5.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
5.4.1. Imaging
5.4.2. Blood Test
5.4.3. Biopsy
5.4.4. Others
Chapter 6. Global Ovarian Cancer Diagnostics Market, by Cancer Type
6.1. Market Snapshot
6.2. Global Ovarian Cancer Diagnostics Market by Cancer Type, Performance – Potential Analysis
6.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
6.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Epithelial Tumor
6.4.2. Germ Cell Tumor
6.4.3. Stromal Cell Tumor
6.4.4. Others
Chapter 7. Global Ovarian Cancer Diagnostics Market, by End Use
7.1. Market Snapshot
7.2. Global Ovarian Cancer Diagnostics Market by End Use, Performance – Potential Analysis
7.3. Global Ovarian Cancer Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
7.4. Ovarian Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Hospital Laboratories
7.4.2. Cancer Diagnostic Centers
7.4.3. Research Institutes
7.4.4. Others
Chapter 8. Global Ovarian Cancer Diagnostics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Ovarian Cancer Diagnostics Market, Regional Market Snapshot
8.4. North America Ovarian Cancer Diagnostics Market
8.4.1. U.S. Ovarian Cancer Diagnostics Market Diagnosis Type breakdown estimates & forecasts, 2020-2030 Cancer Type breakdown estimates & forecasts, 2020-2030 End Use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Ovarian Cancer Diagnostics Market
8.5. Europe Ovarian Cancer Diagnostics Market Snapshot
8.5.1. U.K. Ovarian Cancer Diagnostics Market
8.5.2. Germany Ovarian Cancer Diagnostics Market
8.5.3. France Ovarian Cancer Diagnostics Market
8.5.4. Spain Ovarian Cancer Diagnostics Market
8.5.5. Italy Ovarian Cancer Diagnostics Market
8.5.6. Rest of Europe Ovarian Cancer Diagnostics Market
8.6. Asia-Pacific Ovarian Cancer Diagnostics Market Snapshot
8.6.1. China Ovarian Cancer Diagnostics Market
8.6.2. India Ovarian Cancer Diagnostics Market
8.6.3. Japan Ovarian Cancer Diagnostics Market
8.6.4. Australia Ovarian Cancer Diagnostics Market
8.6.5. South Korea Ovarian Cancer Diagnostics Market
8.6.6. Rest of Asia Pacific Ovarian Cancer Diagnostics Market
8.7. Latin America Ovarian Cancer Diagnostics Market Snapshot
8.7.1. Brazil Ovarian Cancer Diagnostics Market
8.7.2. Mexico Ovarian Cancer Diagnostics Market
8.8. Middle East & Africa Ovarian Cancer Diagnostics Market
8.8.1. Saudi Arabia Ovarian Cancer Diagnostics Market
8.8.2. South Africa Ovarian Cancer Diagnostics Market
8.8.3. Rest of Middle East & Africa Ovarian Cancer Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abcam plc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. F. Hoffmann-La Roche Ltd.
9.3.3. GlaxoSmithKline plc
9.3.4. Johnson & Johnson Services, Inc.
9.3.5. AstraZeneca plc
9.3.6. Siemens Healthcare GmbH
9.3.7. Quest Diagnostics Incorporated.
9.3.8. Thermo Fisher Scientific Inc.
9.3.9. Bio-Rad Laboratories Inc.
9.3.10. Abbott. Laboratories Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now